Yo is a member of the Access to Medicine Index Expert Review Committee since 2016. He is Head of ESG Research and Active Ownership at AXA Investment Managers since 2018. He oversees the delivery of in-depth global sustainability thematic research and leads the engagement programme with investee companies for 740 billion euros of assets under management. He has extensive experience engaging with global pharmaceutical companies on Access to Medicine issues since 2011.
Prior to AXA Investment Managers, he spent seven years working as Director, Governance and Sustainable Investment at BMO Global Asset Management where he led the ESG engagement overlay service and established the listed impact investment practice. He also has previous experiences as a business journalist for the BBC, CNBC, Bloomberg News and Asahi Shimbun.
Yo holds a MBA (distinction) from Cass Business School and a MA / BA (hons) undergraduate degree in Geography from the University of Cambridge.